Trial intelligence / Profile preview

Nebulization vs Spray-as-You-Go Airway Anesthesia in TMJ Ankylosis

NCT06088875Unknown

Sponsor
Tanta University
Start
Oct 2023
Primary completion
May 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of lidocaine 10% oropharyngeal spray and dexmedetomidine in Temporomandibular ankylosis (TMJA) (2 arms), sponsored by Tanta University. Primary endpoint: Ease of successful intubation. Status: unknown.

02

Drugs

lidocaine 10% oropharyngeal spraydexmedetomidine
03

Conditions

Temporomandibular ankylosis (TMJA)

Beyond the preview

Go deeper on NCT06088875.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06088875.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call